Trial Profile
The Effect of Dapagliflozin on Inflammation and Endothelial Function
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 08 Jul 2019 Status changed from recruiting to discontinued.
- 02 Jun 2018 Planned End Date changed from 1 May 2018 to 1 May 2019.
- 02 Jun 2018 Planned primary completion date changed from 1 May 2018 to 1 May 2019.